PS-341 in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell
growth. Phase II trial to study the effectiveness of PS-341 in treating women who have
metastatic breast cancer